The Double Helix, Spring 2022

The Double Helix, Spring 2022

Spring 2022 issue of quarterly NFID eNewsletter covering:

  • The impacts of COVID-19 on vaccine research
  • 2022 Annual Conference on Vaccinology Research (Online)
  • Respiratory syncytial virus (RSV)
  • Influenza (flu)
  • Partner News
  • More …

Message from Headquarters

COVID-19 has had an impact on all of us, both personally and professionally—including the focus of the Annual Conference on Vaccinology Research, which the National Foundation for Infectious Diseases (NFID) has hosted for more than 25 years. During the 2022 online conference next month, leading experts will explore the future of vaccinology research, addressing scientific challenges as well as the global threat of vaccine hesitancy. I hope to ‘see’ many of you there. COVID-19 experiences have taught us much about developing more effective vaccines, and some of these lessons may apply to respiratory syncytial virus (RSV) …